Your session is about to expire
← Back to Search
Pathways for Lung Cancer
N/A
Waitlist Available
Led By Laurie McLouth, PhD
Research Sponsored by Laurie McLouth
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
new or recurrent stage IIIB, stage IIIC or stage IV non-small cell lung cancer (NSCLC) or extensive stage SCLC
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
Study Summary
This trial will test whether the Pathways intervention can help patients with advanced stage and metastatic lung cancer.
Eligible Conditions
- Lung Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability: Ratings
Feasibility of Enrollment: Percentage of Eligible and Approached Patients Who Agree to Participate
Secondary outcome measures
Distress - PROMIS Depression Short Form 6a
Hope - State Hope Scale (Snyder)
Lung Cancer Stigma - Lung Cancer Stigma Inventory (Hamann)
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: PathwaysExperimental Treatment1 Intervention
Pathways is designed to help patients identify and pursue values-based goals and address potential goal obstacles, including lung cancer stigma.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pathways
2020
N/A
~1140
Find a Location
Who is running the clinical trial?
Laurie McLouthLead Sponsor
3 Previous Clinical Trials
354 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,613 Previous Clinical Trials
40,918,262 Total Patients Enrolled
Laurie McLouth, PhDPrincipal Investigator - University of Kentucky
University of Kentucky
2 Previous Clinical Trials
314 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger